Please provide your email address to receive an email when new articles are posted on . The restriction phenotype, typically associated with sarcoidosis, was only found in 47% of patients with ...
NEW YORK & BASEL, Switzerland--(BUSINESS WIRE)--Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare autoimmune and inflammatory diseases, today announced ...
A research project supported by the National Institutes of Health has developed a tool to rapidly and inexpensively diagnose sarcoidosis, a chronic inflammatory disease marked by the growth of tiny ...
BASEL, Switzerland & LONDON & NEW YORK--(BUSINESS WIRE)--Roivant (Nasdaq: ROIV) and Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare inflammatory and ...
Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosis Further development of namilumab for the treatment of sarcoidosis will be discontinued Primary Endpoint Details: ...
The Foundation for Sarcoidosis Research (FSR) brought together more than 40 leading clinicians and researchers from around the world for two landmark events: the inaugural in-person clinician meeting ...
On Sunday, September 24th, Bone Thugs-N-Harmony’s Krayzie Bone, whose real name is Anthony Henderson, was hospitalized and battling a “life-threatening” condition. According to All Hip Hop, the ...
Hosted on MSN
The rare inflammatory condition that is sarcoidosis
Sarcoidosis is a rare inflammatory condition that develops when groups of cells in your immune system form patches of swollen tissue, called granulomas. These can cluster in the organs of the body, ...
Not many people know how to say sarcoidosis (sar-coy-doe-sis). If people can’t say it, it is challenging to raise awareness, educate others about the disease, discuss the disease with physicians and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback